ArticleMolecular and clinical oncology2015

Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients.

Hiroki Osumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.